Philips introduces a breakthrough technology in India fortifying its position in the cardiac ultrasound
Nagpur, Maharashtra –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology debuted EPIQ CVx, an ultrasound system, which is designed with the cardiologist at the forefront of innovation. The system is modeled to provide exceptional image clarity and sharpness, improved exam efficiencies, more robust and reproducible quantification, enabled by anatomical intelligence along with extraordinary processing power.
The EPIQ CVx incorporates TrueVue, giving clinicians the ability to see photorealistic renderings of the heart, which improves cardiac anatomy analysis by offering detailed tissue and depth perception imaging through a new virtual light source. The system provides cardiologists with high image quality through the latest generation OLED monitor, offering a more dynamic, wider viewing angle for side-by-side image comparison.
Dr. Harshawardhan Mardika, Director, Spandan Heart Institute & Research Center, EPIQ CVx cardiac ultrasound solutions with advanced image quality will provide great anatomical insights to cardiologists in India. The TrueVue feature of this innovative solution elevates 3D ultrasound imaging to a new level and could impact diagnostic ability of echocardiography in different clinical scenarios.
Cardiologists face unique and growing challenges in cardiac imaging. Approximately 65 million people in India suffer from cardiovascular disease, and as pressures on healthcare systems continue to increase, clinicians have more patients to examine in less time. With Philips EPIQ CVx, clinicians can perform fast and consistent exams with enhanced diagnostic information, giving them the confidence to provide exceptional care for all patients, including pediatric patients, whose small hearts can be challenging to image/
Mr. Rohit Sathe
President, Philips Healthcare, Indian Subcontinent
EPIQ CVx offers a slew of futuristic features such as the Dynamic Heart Model, which uses anatomical intelligence to automatically quantify left ventricle function to produce a multi-beat analysis for adult patients. The Dynamic Heart Model is proven to reduce the amount of time required to generate a 3D Ejection Fraction, an important quantification measure to learn how well the heart is pumping out blood, by 83%. It also delivers a high degree of robustness and reproducibility, even in patients with a cardiac arrhythmia.
The systems also include the new S9-2 PureWave probe, which simplifies pediatric cardiac exams by displaying high levels of detail and contrast resolution through the single-crystal technology. It also provides tissue information at greater depths and enhances pediatric capability for coronary artery visualization with a single button coronary sub-mode enabling expeditious scans and enhancing workflow.
The EPIQ CVx includes a cardiology-specific user interface that simplifies the exam experience through a user-configurable touch-screen interface, allowing clinicians to personalize their controls and improve workflow for their cardiology exams. Philips also reaffirms its dedication to privacy and security by providing strong security capabilities and protocols.
Philips is a leader in ultrasound solutions with a large global installed base and strong record of accomplishment of industry-first innovations. The company’s ultrasound portfolio supports the effective and efficient delivery of care across a broad range of clinical specialties including radiology, cardiology, point-of-care and OB/GYN.
1Prado A, Narang A, Volpato V, Kumari N, Prater D, Addetia K, Patel AR, Mor-Avi V, Lang RM: Automated dynamic measurement of left heart chamber volumes for quantification of ejection and filling parameters. JASE 31(6):B111; 2018
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips' health technology portfolio generated 2018 sales of EUR 18.1 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at http://www.philips.com/newscenter.
By clicking on the link, you will be leaving the official Royal Philips Healthcare ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.